Key statistics
As of last trade, TriSalus Life Sciences Inc (TLSI:NMQ) traded at 4.35, 20.50% above the 52 week low of 3.61 set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.65 |
---|---|
High | 4.65 |
Low | 4.35 |
Bid | 4.29 |
Offer | 4.51 |
Previous close | 4.53 |
Average volume | 42.12k |
---|---|
Shares outstanding | 29.31m |
Free float | 16.61m |
P/E (TTM) | -- |
Market cap | 132.78m USD |
EPS (TTM) | -1.68 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 15:21 GMT.
More ▼
- TriSalus Reports Q3 2024 Financial Results and Provides Business Update
- TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
- TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
- TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
- TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
- TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
- TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
More ▼